Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review

Although pregnancy remains exceptional in women after heart, liver or lung transplant, obstetricians and nephrologists are regularly confronted with pregnancy in renal transplant recipients. National and international registries have described the epidemiology of maternal, foetal and neonatal compli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical Kidney Journal 2021-08, Vol.14 (8), p.1871-1878
Hauptverfasser: Boulay, Hugoline, Mazaud-Guittot, Séverine, Supervielle, Jeanne, Chemouny, Jonathan M, Dardier, Virginie, Lacroix, Agnes, Dion, Ludivine, Vigneau, Cécile
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1878
container_issue 8
container_start_page 1871
container_title Clinical Kidney Journal
container_volume 14
creator Boulay, Hugoline
Mazaud-Guittot, Séverine
Supervielle, Jeanne
Chemouny, Jonathan M
Dardier, Virginie
Lacroix, Agnes
Dion, Ludivine
Vigneau, Cécile
description Although pregnancy remains exceptional in women after heart, liver or lung transplant, obstetricians and nephrologists are regularly confronted with pregnancy in renal transplant recipients. National and international registries have described the epidemiology of maternal, foetal and neonatal complications, and transplantation societies have published recommendations on the monitoring of these high-risk pregnancies. In this review, we summarize the existing data on maternal and foetal complications of pregnancies in women after renal transplant, especially the management of immunosuppression. We also describe the few available data on the middle- and long-term outcomes of their children who were exposed in utero to immunosuppressive drugs.
doi_str_mv 10.1093/ckj/sfab049
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8323135</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A766560185</galeid><oup_id>10.1093/ckj/sfab049</oup_id><sourcerecordid>A766560185</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-5044f5c9a1c2e3c5edf153e735432c86133c2f6880c473cfe03b2d55717b3d563</originalsourceid><addsrcrecordid>eNp9kt1rFDEQwBdRbKl98h8ICKLotclOsh99EI6ibeHEF30OuexkL3U3WZPdKwX_eLPsIa1IE5gkk998JDNZ9prRM0ZrONc_b8-jUVvK62fZcU55taoEg-cP9kfZaYy3NI10oly8zI6AAxec1sfZ769qxOBU95EYj6PqiHIN0TvbJeldxF8TOo2ReENs30_Ox2kYAsZo90iaMLWRNFOwriVJ2zrl9D2xjtz5HpO044740CpHxqBcHDrlxguiSMC9xbtX2Qujuoinh_Uk-_Hl8_fL69Xm29XN5Xqz0rym40pQzo3QtWI6R9ACG8MEYAmCQ66rggHo3BRVRTUvQRuksM0bIUpWbqERBZxknxa_w7TtsdHoUjadHILtVbiXXln5-MbZnWz9XlaQAwORHLxfHOz-Mbteb-SsowBCAGN7lth3h2DBp8-Lo-xt1Nilp6OfosyFqFLlKjrn9WZBW9WhtM74FF3PuFyXRSEKyqo5-Nl_qDQb7G2qERqb9I8MPiwGOvgYA5q_KTMq566RqWvkoWsS_Xah_TQ8Cf4BwsXCNg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2558093806</pqid></control><display><type>article</type><title>Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review</title><source>Oxford Journals Open Access Collection</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Boulay, Hugoline ; Mazaud-Guittot, Séverine ; Supervielle, Jeanne ; Chemouny, Jonathan M ; Dardier, Virginie ; Lacroix, Agnes ; Dion, Ludivine ; Vigneau, Cécile</creator><creatorcontrib>Boulay, Hugoline ; Mazaud-Guittot, Séverine ; Supervielle, Jeanne ; Chemouny, Jonathan M ; Dardier, Virginie ; Lacroix, Agnes ; Dion, Ludivine ; Vigneau, Cécile</creatorcontrib><description>Although pregnancy remains exceptional in women after heart, liver or lung transplant, obstetricians and nephrologists are regularly confronted with pregnancy in renal transplant recipients. National and international registries have described the epidemiology of maternal, foetal and neonatal complications, and transplantation societies have published recommendations on the monitoring of these high-risk pregnancies. In this review, we summarize the existing data on maternal and foetal complications of pregnancies in women after renal transplant, especially the management of immunosuppression. We also describe the few available data on the middle- and long-term outcomes of their children who were exposed in utero to immunosuppressive drugs.</description><identifier>ISSN: 2048-8513</identifier><identifier>ISSN: 2048-8505</identifier><identifier>EISSN: 2048-8513</identifier><identifier>DOI: 10.1093/ckj/sfab049</identifier><identifier>PMID: 34345409</identifier><language>eng</language><publisher>Oxford University Press</publisher><subject>Antihypertensive drugs ; Antithymocyte globulin ; Belatacept ; Chronic kidney failure ; CKJ Reviews ; Epidemiology ; Gynecology and obstetrics ; Human health and pathology ; Immunology ; Immunotherapy ; Kidneys ; Life Sciences ; Liver ; Organ transplant recipients ; Pediatrics ; Pregnant women ; Transplantation</subject><ispartof>Clinical Kidney Journal, 2021-08, Vol.14 (8), p.1871-1878</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. 2021</rights><rights>COPYRIGHT 2021 Oxford University Press</rights><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-5044f5c9a1c2e3c5edf153e735432c86133c2f6880c473cfe03b2d55717b3d563</citedby><cites>FETCH-LOGICAL-c490t-5044f5c9a1c2e3c5edf153e735432c86133c2f6880c473cfe03b2d55717b3d563</cites><orcidid>0000-0001-6309-3986 ; 0000-0003-0566-4124</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323135/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323135/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://hal.science/hal-03355311$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Boulay, Hugoline</creatorcontrib><creatorcontrib>Mazaud-Guittot, Séverine</creatorcontrib><creatorcontrib>Supervielle, Jeanne</creatorcontrib><creatorcontrib>Chemouny, Jonathan M</creatorcontrib><creatorcontrib>Dardier, Virginie</creatorcontrib><creatorcontrib>Lacroix, Agnes</creatorcontrib><creatorcontrib>Dion, Ludivine</creatorcontrib><creatorcontrib>Vigneau, Cécile</creatorcontrib><title>Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review</title><title>Clinical Kidney Journal</title><description>Although pregnancy remains exceptional in women after heart, liver or lung transplant, obstetricians and nephrologists are regularly confronted with pregnancy in renal transplant recipients. National and international registries have described the epidemiology of maternal, foetal and neonatal complications, and transplantation societies have published recommendations on the monitoring of these high-risk pregnancies. In this review, we summarize the existing data on maternal and foetal complications of pregnancies in women after renal transplant, especially the management of immunosuppression. We also describe the few available data on the middle- and long-term outcomes of their children who were exposed in utero to immunosuppressive drugs.</description><subject>Antihypertensive drugs</subject><subject>Antithymocyte globulin</subject><subject>Belatacept</subject><subject>Chronic kidney failure</subject><subject>CKJ Reviews</subject><subject>Epidemiology</subject><subject>Gynecology and obstetrics</subject><subject>Human health and pathology</subject><subject>Immunology</subject><subject>Immunotherapy</subject><subject>Kidneys</subject><subject>Life Sciences</subject><subject>Liver</subject><subject>Organ transplant recipients</subject><subject>Pediatrics</subject><subject>Pregnant women</subject><subject>Transplantation</subject><issn>2048-8513</issn><issn>2048-8505</issn><issn>2048-8513</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNp9kt1rFDEQwBdRbKl98h8ICKLotclOsh99EI6ibeHEF30OuexkL3U3WZPdKwX_eLPsIa1IE5gkk998JDNZ9prRM0ZrONc_b8-jUVvK62fZcU55taoEg-cP9kfZaYy3NI10oly8zI6AAxec1sfZ769qxOBU95EYj6PqiHIN0TvbJeldxF8TOo2ReENs30_Ox2kYAsZo90iaMLWRNFOwriVJ2zrl9D2xjtz5HpO044740CpHxqBcHDrlxguiSMC9xbtX2Qujuoinh_Uk-_Hl8_fL69Xm29XN5Xqz0rym40pQzo3QtWI6R9ACG8MEYAmCQ66rggHo3BRVRTUvQRuksM0bIUpWbqERBZxknxa_w7TtsdHoUjadHILtVbiXXln5-MbZnWz9XlaQAwORHLxfHOz-Mbteb-SsowBCAGN7lth3h2DBp8-Lo-xt1Nilp6OfosyFqFLlKjrn9WZBW9WhtM74FF3PuFyXRSEKyqo5-Nl_qDQb7G2qERqb9I8MPiwGOvgYA5q_KTMq566RqWvkoWsS_Xah_TQ8Cf4BwsXCNg</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Boulay, Hugoline</creator><creator>Mazaud-Guittot, Séverine</creator><creator>Supervielle, Jeanne</creator><creator>Chemouny, Jonathan M</creator><creator>Dardier, Virginie</creator><creator>Lacroix, Agnes</creator><creator>Dion, Ludivine</creator><creator>Vigneau, Cécile</creator><general>Oxford University Press</general><scope>TOX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6309-3986</orcidid><orcidid>https://orcid.org/0000-0003-0566-4124</orcidid></search><sort><creationdate>20210801</creationdate><title>Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review</title><author>Boulay, Hugoline ; Mazaud-Guittot, Séverine ; Supervielle, Jeanne ; Chemouny, Jonathan M ; Dardier, Virginie ; Lacroix, Agnes ; Dion, Ludivine ; Vigneau, Cécile</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-5044f5c9a1c2e3c5edf153e735432c86133c2f6880c473cfe03b2d55717b3d563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antihypertensive drugs</topic><topic>Antithymocyte globulin</topic><topic>Belatacept</topic><topic>Chronic kidney failure</topic><topic>CKJ Reviews</topic><topic>Epidemiology</topic><topic>Gynecology and obstetrics</topic><topic>Human health and pathology</topic><topic>Immunology</topic><topic>Immunotherapy</topic><topic>Kidneys</topic><topic>Life Sciences</topic><topic>Liver</topic><topic>Organ transplant recipients</topic><topic>Pediatrics</topic><topic>Pregnant women</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boulay, Hugoline</creatorcontrib><creatorcontrib>Mazaud-Guittot, Séverine</creatorcontrib><creatorcontrib>Supervielle, Jeanne</creatorcontrib><creatorcontrib>Chemouny, Jonathan M</creatorcontrib><creatorcontrib>Dardier, Virginie</creatorcontrib><creatorcontrib>Lacroix, Agnes</creatorcontrib><creatorcontrib>Dion, Ludivine</creatorcontrib><creatorcontrib>Vigneau, Cécile</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical Kidney Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boulay, Hugoline</au><au>Mazaud-Guittot, Séverine</au><au>Supervielle, Jeanne</au><au>Chemouny, Jonathan M</au><au>Dardier, Virginie</au><au>Lacroix, Agnes</au><au>Dion, Ludivine</au><au>Vigneau, Cécile</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review</atitle><jtitle>Clinical Kidney Journal</jtitle><date>2021-08-01</date><risdate>2021</risdate><volume>14</volume><issue>8</issue><spage>1871</spage><epage>1878</epage><pages>1871-1878</pages><issn>2048-8513</issn><issn>2048-8505</issn><eissn>2048-8513</eissn><abstract>Although pregnancy remains exceptional in women after heart, liver or lung transplant, obstetricians and nephrologists are regularly confronted with pregnancy in renal transplant recipients. National and international registries have described the epidemiology of maternal, foetal and neonatal complications, and transplantation societies have published recommendations on the monitoring of these high-risk pregnancies. In this review, we summarize the existing data on maternal and foetal complications of pregnancies in women after renal transplant, especially the management of immunosuppression. We also describe the few available data on the middle- and long-term outcomes of their children who were exposed in utero to immunosuppressive drugs.</abstract><pub>Oxford University Press</pub><pmid>34345409</pmid><doi>10.1093/ckj/sfab049</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-6309-3986</orcidid><orcidid>https://orcid.org/0000-0003-0566-4124</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2048-8513
ispartof Clinical Kidney Journal, 2021-08, Vol.14 (8), p.1871-1878
issn 2048-8513
2048-8505
2048-8513
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8323135
source Oxford Journals Open Access Collection; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Antihypertensive drugs
Antithymocyte globulin
Belatacept
Chronic kidney failure
CKJ Reviews
Epidemiology
Gynecology and obstetrics
Human health and pathology
Immunology
Immunotherapy
Kidneys
Life Sciences
Liver
Organ transplant recipients
Pediatrics
Pregnant women
Transplantation
title Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T17%3A49%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Maternal,%20foetal%20and%20child%20consequences%20of%20immunosuppressive%20drugs%20during%20pregnancy%20in%20women%20with%20organ%20transplant:%20a%20review&rft.jtitle=Clinical%20Kidney%20Journal&rft.au=Boulay,%20Hugoline&rft.date=2021-08-01&rft.volume=14&rft.issue=8&rft.spage=1871&rft.epage=1878&rft.pages=1871-1878&rft.issn=2048-8513&rft.eissn=2048-8513&rft_id=info:doi/10.1093/ckj/sfab049&rft_dat=%3Cgale_pubme%3EA766560185%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2558093806&rft_id=info:pmid/34345409&rft_galeid=A766560185&rft_oup_id=10.1093/ckj/sfab049&rfr_iscdi=true